Raquel Freitas

Dr. Raquel Freitas


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Processes
Verified
Journal Article
Open access
PDF file
RSRicardo Santos
Ricardo Santos
RARenata Assis
Renata Assis
RFRaquel Freitas
Raquel Freitas
IBIsabele Barbosa
Isabele Barbosa
Vania CeccattoVania Ceccatto
Vania Ceccatto
Rapadura is a well-recognized sugar-cane-derived product with a sweet, characteristic flavor and hard texture. This product is a cultural Brazilian landmark, particularly in Ceará, Brazil, where it is usually produced by small family businesses and consumed locally. This feature contributes to the difficulties of rapadura production standardization, a requirement for the global market. Against this backdrop, this study focuses on analyzing the centesimal composition and mineral content of rapadura. Six samples from different cities in Ceará were analyzed for moisture, ash, lipids, proteins, carbohydrates, energy value, and minerals. The results ranged from 6.42–11.74% for moisture, 0.23–1.12% for ash, 0.49–0.92% for protein, 85.18–89.12% for lipids, and 352.00–391.19 Kcal for energy value. Significant variations were observed between the samples, showing a lack of standardization in the production process. The analysis of micronutrients revealed low levels, with copper and iron standing out in sample D. It can be concluded that the rapadura analyzed meets the physical-chemical parameters established by national legislation and is a food rich in carbohydrates and energy.

1 January 2024 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
RFRaquel Freitas
Raquel Freitas
SFS. M. S. Felipe
S. M. S. Felipe
JRJ. K. C. Ribeiro
J. K. C. Ribeiro
VAValdevane Rocha Araújo
Valdevane Rocha Araújo
CMC. P. S. Martin
C. P. S. Martin
Vania CeccattoVania Ceccatto
Vania Ceccatto
MicroRNAs (miRNAs) are recognized as diabetes mellitus type 2 (T2DM) biomarkers useful for disease metabolism comprehension and have great potential as therapeutics targets. BDNF and IGF1 increased expression are highly involved in the benefits of insulin and glucose paths, however, they are down-regulated in insulin resistance conditions, while their expression increase is correlated to the improvement of glucose and insulin metabolism. Studies suggest the microRNA regulation of these genes in several different contexts, providing a novel investigation approach for comprehending T2DM metabolism and revealing potential therapeutic targets. In the present study, we investigate in different animal models (human, rat, and mouse) miRNAs that target BDNF and IGF1 in skeletal muscle tissue with T2DM physiological conditions. Bioinformatics tools and databases were used to miRNA prediction, molecular homology, experimental validation of interactions, expression in the studied physiological condition, and network interaction. The findings showed three miRNAs candidates for IGF1(miR-29a, miR-29b, and miR-29c) and one for BDNF (miR-206). The experimental evaluations and the search for the expression in skeletal muscle from T2DM subjects confirmed the predicted interaction between miRNA-mRNA for miR-29b and miR-206 through human, rat, and mouse models. This interaction was reaffirmed in multiple network analyses. In conclusion, our results show the regulation relationship between miR-29b and miR-206 with the investigated genes, in several tissues, suggesting an inhibition pattern. Nevertheless, these data show a large number of possible interaction physiological processes, for future biotechnological prospects.

29 April 2022 in Processes
Verified
Journal Article
Open access
PDF file
KSKarla Camila Lima de Souza
Karla Camila Lima de Souza
ABAnderson Marcio de Lima Batista
Anderson Marcio de Lima Batista
EDEden Batista Duarte
Eden Batista Duarte
JMJonathan Elias Rodrigues Martins
Jonathan Elias Rodrigues Martins
AFAntônio Nadson Modesto Filho
Antônio Nadson Modesto Filho
Vania CeccattoVania Ceccatto
Vania Ceccatto
The diabetic foot is characterized by the loss of foot ulcerations and sensitivity. The use of orthopedic orthosis can prevent pathological changes in the diabetic foot. The objective of this study was to characterize materials used for producing orthopedic orthosis: silicone; pre-vulcanized latex of Hevea brasiliensis; Evapod, and Podadur. The Hevea brasiliensis latex material is widely indicated in the literature for biomedical purposes. Physical–mechanical properties were determined (properties of elastic deformation, resistance, durability, lightness, energy absorption, resistance to high temperatures, and chemical composition—ASTM International). In the tensile test, the latex reached 6.02 ± 0.33 MPa, having the best performance among the other materials. In the elastic module, the Podadur stood out, with 28.2 ± 0.89 MPa, compared to silicone with 0.42 ± 0.05 MPa. The most excellent Shore A hardness material was Podadur with 58%. As for the resilience, the Podadur presented a minimum value of 22%, while latex had 63%. Silicone was the densest material, with a density of 1.48 g/cm3, and Evapod and Podadur were the lightest, respectively, at 0.22 g/cm3 and 0.42 g/cm3. Morphologically, Evapod, Podadur, and latex presented open and interconnected cells, characteristics that gave them a more significant water absorption capacity. Silicone was the only material with no empty cells in its structure. In X-ray diffraction, Evapod, Podadur, and silicone materials presented well-defined crystallographic planes, whereas amorphous behavior characterized latex. Thermogravimetry showed weight loss between 240 and 650 °C in the four materials. In the fluorescence test, the presence of metals was observed in the composition of the four materials. Among the materials studied, the Podadur was the material that stood out, with some good properties for the development of orthopedic orthosis.

5 December 2021 in Latin American Data in Science
Verified
Journal Article
Open access
PDF file
CPChristina Pacheco
Christina Pacheco
SFStela Mirla Silva Felipe
Stela Mirla Silva Felipe
JAJuliana Alves
Juliana Alves
RFRaquel Freitas
Raquel Freitas
LSLuis Henrique Pontes dos Santos
Luis Henrique Pontes dos Santos
Vania CeccattoVania Ceccatto
Vania Ceccatto
Physical exercise (PE) in regularity is a well-characterized non-pharmaceutical intervention for good health and welfare. Molecular mechanisms regulated in response to PE can be scrutinized, with molecular biology, genomics, transcriptomics, and bioinformatics being inserted into exercise physiology studies. From a biotechnological perspective, omic datasets about physical exercise gene expression help identify phenotypic, genetic variance for different physical training phenotypes. Extensive lists of genes regulated by PE were dispersed within the literature, and the Fitnome Catalog (FitC) was created to reach some systematization of this information. Manual and online text-mining tools generated this dataset in PE human gene expression articles (2003-2014) with microarray, RNA-Seq, RT-PCR, and genotyping methods. Spreadsheets were developed with information on exercise protocol, experimental design, gender, age, number of individuals, analytical approach, gene ID, fold change and statistical data, and genetic architecture, encompassing 21 columns. The produced dataset (with 5,147 genes and 101,343 data points) provides experimental design, gene expression information, gene attributes, and references. Functional categorization of the FitC dataset and standardized information on PE-expressed genes were presented.

14 May 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
RFRaquel Freitas
Raquel Freitas
SFStela Felipe
Stela Felipe
CPChristina Pacheco
Christina Pacheco
EFEmmanuelle Faria
Emmanuelle Faria
JMJonathan Martins
Jonathan Martins
Vania CeccattoVania Ceccatto
Vania Ceccatto
Background/Objectives: MicroRNAs (miRNAs) are molecules involved in biological regulation processes, including type 2 diabetes and its complications development. Single nucleotide polymorphisms (SNPs) can alter miRNA mechanisms, resulting in loss or gain effects. VEGFA is recognized for its role in angiogenesis. However, its overexpression can lead to deleterious effects, such as disorganized and inefficient vasculature. Under hyperglycemic conditions, VEGFA expression seems to increase, which may contribute to the development of microvascular and macrovascular diabetic complications. Several miRNAs are associated with VEGFA regulation and seem to act in the prevention of dysregulated expression. This study aimed to investigate SNPs in miRNA regions related to the loss effect in VEGFA regulation, examining their frequency and potential physiological effects in the development of diabetic complications. Methods: VEGFA-targeting miRNAs were identified using the R package multimiR, with validated and predicted results. Tissue expression analysis and SNP search were data-mined with Python 3 for miRNASNP-v3 SNP raw databases. Allele frequencies were obtained from dbSNP. The miRNA–mRNA interaction comparison was obtained in the miRmap tool through Python 3. MalaCards were used to infer physiological disease association. Results: The variant rs371699284 was selected in hsa-miR-654-3p among 103 potential VEGFA-targeting miRNAs. This selected SNP demonstrated promising results in bioinformatics predictions, tissue-specific expression, and population frequency, highlighting its potential role in miRNA regulation and the resulting loss in VEGFA-silencing efficiency. Conclusions: Our findings suggest that carriers of rs1238947970 may increase susceptibility to diabetic microvascular and macrovascular complications. Furthermore, in vitro and in silico studies are necessary to better understand these processes.

17 July 2026 in Disciplinarum Scientia - Ciências Naturais e Tecnológicas
Verified
Journal Article
Open access
PDF file
HCHudson Pimentel Costa
Hudson Pimentel Costa
MGMaria Guedes
Maria Guedes
RFRaquel Freitas
Raquel Freitas
SAStela Mirla da Silva Felipe Acácio
Stela Mirla da Silva Felipe Acácio
Vania CeccattoVania Ceccatto
Vania Ceccatto
Contexto: A carnaúba (Copernicia prunifera), palmeira nativa do semiárido brasileiro, destaca-se por sua relevância econômica e por seu potencial como fonte de compostos bioativos. Nesse contexto, distúrbios metabólicos, como diabetes, hiperlipidemia, estresse oxidativo e inflamação, constituem importantes desafios de saúde pública, reforçando o interesse na investigação de novas alternativas terapêuticas derivadas dessa espécie. Objetivo: Este estudo teve como objetivo revisar sistematicamente as evidências científicas relacionadas aos efeitos terapêuticos de bioprodutos derivados da carnaúba entre 2015 e 2024. Métodos: Por meio de uma revisão sistemática realizada nas bases de dados Google Scholar, Science Direct, PubMed, SciELO e Web of Science. Vinte e dois (22) estudos atenderam aos critérios de inclusão e exclusão previamente definidos e foram incluídos na síntese qualitativa. Resultados: Os resultados indicam que bioprodutos derivados da carnaúba apresentam significativo potencial farmacológico e tecnológico, especialmente no contexto dos distúrbios metabólicos, além de demonstrarem elevados perfis de biocompatibilidade e segurança em diferentes modelos experimentais animais. A cera de carnaúba destaca-se como uma matriz promissora para liberação controlada de fármacos, melhorando a estabilidade e a biodisponibilidade de compostos ativos. A produção científica é majoritariamente brasileira, com crescente colaboração internacional. Conclusões: Contudo, ainda são necessários estudos translacionais e clínicos para validar suas aplicações terapêuticas e industriais.